Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Cash from Financing Activities (2019 - 2024)

MediXall's Cash from Financing Activities history spans 8 years, with the latest figure at $397037.0 for Q3 2024.

  • For Q3 2024, Cash from Financing Activities rose 55.69% year-over-year to $397037.0; the TTM value through Sep 2024 reached $1.2 million, down 21.6%, while the annual FY2023 figure was $1.2 million, 64.69% down from the prior year.
  • Cash from Financing Activities reached $397037.0 in Q3 2024 per MDXL's latest filing, up from $273046.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $2.0 million in Q1 2021 to a low of $202500.0 in Q4 2023.
  • Average Cash from Financing Activities over 5 years is $752372.9, with a median of $527498.0 recorded in 2022.
  • The largest YoY upside for Cash from Financing Activities was 292.0% in 2021 against a maximum downside of 74.06% in 2021.
  • A 5-year view of Cash from Financing Activities shows it stood at $1.5 million in 2020, then tumbled by 51.69% to $708000.0 in 2021, then decreased by 25.49% to $527498.0 in 2022, then tumbled by 61.61% to $202500.0 in 2023, then soared by 96.07% to $397037.0 in 2024.
  • Per Business Quant, the three most recent readings for MDXL's Cash from Financing Activities are $397037.0 (Q3 2024), $273046.0 (Q2 2024), and $351940.0 (Q1 2024).